Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China
· Delayed Price · Currency is CNY 16.69
+0.17 (1.03%)
May 30, 2025, 2:45 PM CST
SHA:603858 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -360.55 | -553.8 | 318.97 | -1,530 | 1,289 | 1,861 | Upgrade
|
| Depreciation & Amortization | 450.25 | 450.25 | 592.57 | 497.56 | 510.43 | 424.55 | Upgrade
|
| Other Amortization | 219.62 | 219.62 | 64.71 | 38.19 | 3.48 | 2.03 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.43 | -0.43 | -1.53 | -0.77 | -1.68 | -1.13 | Upgrade
|
| Asset Writedown & Restructuring Costs | 855.33 | 855.33 | 602.34 | 2,944 | 12.42 | 1.91 | Upgrade
|
| Loss (Gain) From Sale of Investments | -12.87 | -12.87 | -18.94 | 54.06 | 42.39 | -15.62 | Upgrade
|
| Provision & Write-off of Bad Debts | -25.57 | -25.57 | 8.08 | 4.41 | 15.12 | 1.45 | Upgrade
|
| Other Operating Activities | 466.11 | 55.46 | -22.29 | 72.17 | 100.81 | 107.6 | Upgrade
|
| Change in Accounts Receivable | 583.89 | 583.89 | 83.68 | 483.36 | 363.14 | -648.66 | Upgrade
|
| Change in Inventory | 228.76 | 228.76 | -1,186 | 39.52 | -1,066 | -847.77 | Upgrade
|
| Change in Accounts Payable | -820.28 | -820.28 | -493.59 | 172.01 | 92.54 | 1,058 | Upgrade
|
| Operating Cash Flow | 1,544 | 939.95 | -195.61 | 2,756 | 1,321 | 1,959 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 108.68% | -32.58% | -25.28% | Upgrade
|
| Capital Expenditures | -147.15 | -197 | -529.92 | -543.17 | -433.53 | -536.44 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.57 | 0.49 | 2.4 | 0.48 | 1.45 | 10.23 | Upgrade
|
| Cash Acquisitions | - | - | 0.75 | - | -272.7 | 66.43 | Upgrade
|
| Divestitures | -0 | -0 | -0.2 | - | -0.04 | 21.66 | Upgrade
|
| Investment in Securities | -365.75 | -63.55 | 328.37 | -478.96 | -46.91 | -28.51 | Upgrade
|
| Other Investing Activities | 12.39 | 10.51 | 30.6 | 11.47 | 96.05 | 44.91 | Upgrade
|
| Investing Cash Flow | -499.93 | -249.55 | -168 | -1,010 | -655.67 | -421.72 | Upgrade
|
| Long-Term Debt Issued | - | 2,306 | 1,505 | 2,295 | 3,173 | 3,079 | Upgrade
|
| Total Debt Issued | 1,983 | 2,306 | 1,505 | 2,295 | 3,173 | 3,079 | Upgrade
|
| Long-Term Debt Repaid | - | -1,905 | -1,355 | -2,722 | -3,154 | -2,438 | Upgrade
|
| Total Debt Repaid | -1,805 | -1,905 | -1,355 | -2,722 | -3,154 | -2,438 | Upgrade
|
| Net Debt Issued (Repaid) | 178.26 | 401.54 | 150.1 | -426.96 | 18.9 | 641.75 | Upgrade
|
| Repurchase of Common Stock | -702.34 | -702.34 | -9.99 | - | - | - | Upgrade
|
| Common Dividends Paid | -268.79 | -272.44 | -1,194 | -547.34 | -746.21 | -2,488 | Upgrade
|
| Other Financing Activities | 167.23 | 8.02 | -11.24 | -13.27 | -43.57 | -39.5 | Upgrade
|
| Financing Cash Flow | -625.64 | -565.21 | -1,065 | -987.57 | -770.88 | -1,886 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | 0.01 | 0.01 | 0.16 | -0.34 | -0.01 | Upgrade
|
| Net Cash Flow | 418.27 | 125.2 | -1,429 | 758.04 | -106.38 | -348.95 | Upgrade
|
| Free Cash Flow | 1,397 | 742.96 | -725.52 | 2,212 | 886.98 | 1,422 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 149.44% | -37.64% | -27.40% | Upgrade
|
| Free Cash Flow Margin | 12.53% | 6.75% | -5.48% | 14.80% | 5.63% | 8.89% | Upgrade
|
| Free Cash Flow Per Share | 1.30 | 0.69 | -0.66 | 2.00 | 0.80 | 1.29 | Upgrade
|
| Cash Interest Paid | - | - | - | 5.02 | - | - | Upgrade
|
| Cash Income Tax Paid | 1,286 | 1,419 | 1,819 | 1,915 | 2,308 | 2,116 | Upgrade
|
| Levered Free Cash Flow | 1,856 | 1,368 | -558.66 | 1,955 | 915.43 | 869.9 | Upgrade
|
| Unlevered Free Cash Flow | 1,937 | 1,449 | -489.95 | 2,040 | 1,020 | 960.56 | Upgrade
|
| Change in Net Working Capital | -888.05 | -551.16 | 1,265 | -937.07 | 148.37 | 358.85 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.